Verig Tablet 5 mg contains Vericiguat, a soluble guanylate cyclase (sGC) stimulator used for the treatment of heart failure, specifically in patients with chronic heart failure and reduced ejection fraction (HFrEF). Vericiguat works by enhancing the nitric oxide–sGC–cyclic GMP pathway, which helps relax blood vessels, reduce cardiac stress, and improve heart pumping efficiency.
This medication is particularly prescribed for patients who remain symptomatic despite standard heart failure therapy, including ACE inhibitors, beta-blockers, and diuretics. By supporting better heart function, Verig helps reduce hospitalizations related to worsening heart failure and improves quality of life.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each tablet contains:
Vericiguat 5 mg
Vericiguat stimulates soluble guanylate cyclase (sGC), an enzyme in the cardiovascular system, enhancing the production of cyclic GMP. Increased cyclic GMP levels lead to:
Relaxation of vascular smooth muscle
Reduced cardiac preload and afterload
Improved cardiac efficiency and reduced ventricular stress
This mechanism addresses key pathophysiological processes in chronic heart failure and helps manage disease progression.
Verig Tablet 5 mg is indicated for:
Chronic heart failure with reduced ejection fraction (HFrEF)
Patients with symptomatic heart failure despite optimal standard therapy
Reducing the risk of heart failure hospitalization and cardiovascular death
The dose of Verig Tablet should be determined by a cardiologist or healthcare provider:
Typically initiated at 5 mg once daily
Administer orally, preferably at the same time each day
Dose may be gradually increased based on patient tolerance and blood pressure monitoring
Can be taken with or without food
Regular monitoring of blood pressure and kidney function is recommended during treatment.
Supports improved heart function and cardiac output
Reduces hospitalizations due to worsening heart failure
Provides a complementary therapy to standard heart failure treatments
Convenient once-daily oral dosing
Enhances quality of life in patients with chronic heart failure
Vericiguat is generally well-tolerated, but some patients may experience:
Low blood pressure (hypotension)
Dizziness or lightheadedness
Headache
Fatigue
Nausea
Patients should seek immediate medical attention if severe hypotension, fainting, or allergic reactions occur.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Use only under medical supervision
Not recommended in patients with severe hypotension or cardiogenic shock
Caution is advised in patients with impaired kidney or liver function
Inform your healthcare provider about other medications to avoid potential interactions
Regular follow-up and monitoring are essential for safe and effective therapy
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Verig Tablet 5 mg provides an effective treatment option for chronic heart failure with reduced ejection fraction. When used under medical supervision, it helps improve heart function, reduce hospitalizations, and enhance patient well-being.
Login Or Registerto submit your questions to seller
No none asked to seller yet